Latest market price
2.61
+0.02+0.77%
TA
Loading chart...
Snapshot
| Index | — | P/E | 26.10 | EPS (ttm) | 0.10 | Insider Own | — | Shs Outstand | 286.42M | Perf Week | 6.53% |
| Market Cap | 747.55M | Forward P/E | 10.33 | EPS next Y | 0.25 | Insider Trans | -0.13% | Shs Float | 148.72M | Perf Month | 18.64% |
| Enterprise Value | 1.93B | PEG | — | EPS next Q | 0.04 | Short Float | 13.07% | Perf Quarter | -10.31% | ||
| Income | 30.00M | P/S | 0.13 | EPS this Y | 74.55% | Short Ratio | 8.86 | Perf Half Y | -9.38% | ||
| Sales | 5.96B | P/B | 0.62 | EPS next Y | -1.25% | ROA | 0.59% | Short Interest | 19.44M | Perf YTD | -7.12% |
| Book/sh | 4.21 | P/C | 2.55 | EPS next 5Y | — | ROE | 2.58% | 52W High | 3.78 -30.95% | Perf Year | -25.43% |
| Cash/sh | 1.02 | P/FCF | 2.43 | EPS past 3/5Y | -54.66% — | ROIC | 3.33% | 52W Low | 2.14 21.96% | Perf 3Y | -19.44% |
| Dividend Est. | — | EV/EBITDA | 5.68 | Sales past 3/5Y | -0.42% 3.91% | Gross Margin | 38.81% | Volatility | 3.44% 4.00% | Perf 5Y | -88.98% |
| Dividend TTM | — | EV/Sales | 0.32 | EPS Y/Y TTM | — | Oper. Margin | 2.24% | ATR (14) | 0.10 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 0.39 | Sales Y/Y TTM | -1.32% | Profit Margin | 0.51% | RSI (14) | 65.57 | Recom | 2.68 |
| Dividend Gr. 3/5Y | — | Current Ratio | 0.90 | EPS Q/Q | 4.66% | SMA20 | 9.78% | Beta | 1.51 | Target Price | 3.80 |
| Payout | 0.00% | Debt/Eq | 1.22 | Sales Q/Q | 0.00% | SMA50 | 6.96% | Rel Volume | 1.49 | Prev Close | 2.59 |
| Employees | 29,000 | LT Debt/Eq | 1.21 | Earnings | Nov 24 | SMA200 | -2.17% | Avg Volume | 2.51M | Price | 2.61 |
| IPO Date | Jan 14, 2021 | Option/Short | No / Yes | EPS/Sales Surpr. | 18.48% -0.24% | Net Debt/EBITDA | 3.48 | Volume | 3,748,287 | Change | 0.77% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-03-26 | Reiterated | Robert W. Baird | $3.00 → $3.25 | |
| Sep-01-26 | Reiterated | Evercore ISI Group | In Line | $3.50 → $4.00 |
| Jun-05-26 | Reiterated | Goldman Sachs | Buy | $3.83 → $4.14 |
| Mar-16-26 | Reiterated | UBS | Neutral | $3.50 → $4.00 |
| Mar-12-26 | Reiterated | BNP Paribas | Underperform | $2.18 |
| Mar-12-26 | Reiterated | Evercore ISI | In Line | $3.00 → $3.50 |
| Mar-12-26 | Upgrade | Jefferies | Hold → Buy | |
| Dec-02-25 | Reiterated | Goldman Sachs | Buy | $5.14 → $4.53 |
| Nov-26-25 | Reiterated | Morgan Stanley | Equal Weight | $4.50 → $3.75 |
| Nov-24-25 | Reiterated | UBS | Neutral | $3.70 → $3.50 |
Latest News· Times ET
Oct-28-26
Oct-26-26
07:10AM
Oct-24-26
Oct-23-26
Oct-22-26
Oct-21-26
Oct-15-26
Oct-13-26
Oct-13-2608:02AM
07:15AM
Oct-09-26
06:46AM
Oct-07-26
Oct-05-26
Oct-02-26
Oct-02-2610:35AM
Company
Petco Health and Wellness Company, Inc. operates as an enterprise focused on enhancing the well-being of companion animals, their human guardians, and its own associates. The company offers a broad spectrum of services, including veterinary care (provided both in-store and through its Vetco mobile clinics), grooming, pet training, telehealth consultations, and specialized offerings like Vital Care and pet health insurance. Customers can also procure various pet consumables, supplies, and supplementary services via its digital platforms, such as petco.com, petcoach.co, petinsurancequotes.com, and pupbox.com. As of March 23, 2022, Petco maintained a significant retail footprint with approximately 1,500 locations across the United States, Mexico, and Puerto Rico, a network that included about 200 integrated in-store veterinary hospitals. Established in 1965, the company's central operations are based in San Diego, California.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 1/31/2026 | FY 2024 2/1/2025 | FY 2023 2/3/2024 | FY 2022 1/28/2023 | FY 2021 1/29/2022 | FY 2020 1/30/2021 | FY 2019 2/1/2020 | FY 2018 2/2/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,965 | 5,961 | 6,116 | 6,255 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 3,649 | 3,656 | 3,792 | 3,901 | — | — | — | — | — | |
| Gross Profit | 2,315 | 2,305 | 2,324 | 2,354 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 2,182 | 2,185 | 2,317 | 2,312 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 0 | 1,222 | — | — | — | — | — | |
| Operating Income | 134 | 120 | 7 | -1,180 | — | — | — | — | — | |
| Interest Expense | 131 | 131 | 144 | 151 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 7 | 26 | 27 | 23 | — | — | — | — | — | |
| Net Income Before Taxes | 12 | 15 | -109 | -1,308 | — | — | — | — | — | |
| Income Taxes | -14 | 6 | -7 | -28 | — | — | — | — | — | |
| Consolidated Net Income | 30 | 9 | -102 | -1,280 | — | — | — | — | — | |
| Net Income From Continuing Operations | 24 | 9 | -102 | -1,280 | — | — | — | — | — | |
| Net Income | 30 | 9 | -102 | -1,280 | — | — | — | — | — | |
| EPS (Recurring) | 0.11 | 0.03 | -0.37 | -4.78 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.11 | 0.03 | -0.37 | -4.78 | — | — | — | — | — | |
| EPS (Diluted) | 0.10 | 0.03 | -0.37 | -4.78 | — | — | — | — | — | |
| EBITDA | 340 | 343 | 215 | -972 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 26.10 | 84.86 | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.13 | 0.13 | 0.15 | 0.11 | — | — | — | — | — | |
| Gross Margin | 38.81 | 38.67 | 38.00 | 37.63 | — | — | — | — | — | |
| Operating Margin | 2.25 | 2.01 | 0.11 | -18.86 | — | — | — | — | — | |
| Net Margin | 0.50 | 0.15 | -1.67 | -20.46 | — | — | — | — | — | |
| Shares Outstanding | 286 | 280 | 273 | 268 | — | — | — | — | — | |
| Market Capitalization | 746 | 753 | 934 | 665 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| May Holly | Chief Human Resources Officer | Jul 09 '26 | Sale | 2.54 | 200,000 | 508,000 | 1,327,867 | Jul 10 |
| May Holly | Chief Human Resources Officer | Jul 08 '26 | Sale | 2.55 | 150,000 | 382,500 | 1,527,867 | Jul 09 |
| May Holly | Chief Human Resources Officer | Jul 07 '26 | Sale | 2.55 | 100,000 | 255,000 | 1,677,867 | Jul 09 |
| Venezia Patrick J | Chief Revenue Officer | Mar 13 '26 | Option Exercise | 2.46 | 58,805 | 144,660 | 500,861 | Mar 17 |
| Venezia Patrick J | Chief Revenue Officer | Mar 13 '26 | Sale | 3.42 | 102,029 | 349,072 | 398,832 | Mar 17 |
| Venezia Patrick J | Chief Revenue Officer | Dec 01 '25 | Sale | 3.08 | 74,192 | 228,511 | 474,848 | Dec 03 |
| Anderson Joel D | Chief Executive Officer | Mar 31 '25 | Buy | 3.03 | 849,541 | 2,574,109 | 853,304 | Apr 01 |
| Anderson Joel D | Chief Executive Officer | Mar 28 '25 | Buy | 2.91 | 736,547 | 2,143,352 | 736,547 | Apr 01 |
| Breitner Cameron | Director | May 29 '24 | Buy | 3.14 | 750,000 | 2,354,325 | 750,000 | May 29 |
| BRIGGS GARY S | Director | Dec 01 '23 | Buy | 3.33 | 30,000 | 99,924 | 70,085 | Dec 04 |
| COUGHLIN RON | CEO & Chairman | Mar 28 '23 | Buy | 8.27 | 61,040 | 504,801 | 618,317 | Mar 29 |
| Tichy Justin | Officer | Oct 20 '22 | Sale | 9.85 | 6,500 | 64,025 | 341,254 | Oct 24 |
| Tichy Justin | Chief Pet Care Center Officer | Jul 07 '22 | Sale | 15.74 | 6,500 | 102,310 | 78,142 | Jul 11 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.